Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study
NCT ID: NCT03197259
Last Updated: 2021-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2017-01-01
2026-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
International Chronic Myeloid Leukemia Pediatric Study
NCT01281735
C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia
NCT03150849
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION
NCT07313982
Childhood Acute Lymphoblastic Leukaemia: Follow-Up
NCT03545659
Understanding Chronic Lymphocytic Leukemia
NCT04028531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older
* Able and willing to provide the written informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fatih Demirkan, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatih Demirkan, MD
Board member
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fatih Demirkan, Prof
Role: PRINCIPAL_INVESTIGATOR
Dokuz Eylum Medical Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dokuz Eylum Medical Favulty
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Fatih Demirkan, Prof
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLL TR Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.